Johnson & Johnson on Tuesday asked the Food and Drug Administration (FDA) to authorize a second shot of its COVID-19 vaccine.
The New Jersey-based company officially asked for an expansion of the emergency use authorization that U.S. regulators granted in late February for the single-shot vaccine.